<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
   <channel>
      <title>Lung Cancer News</title>
      <link>http://poznaisebya.com/newseng/lung-cancer-news/</link>
      <description>Lung Cancer News</description>
      <language>en-en</language>
      <webMaster>padayatra@bk.ru</webMaster>
      <copyright>http://poznaisebya.com/newseng</copyright>
      <pubDate>Sat, 22 Nov 2008 17:22:01 GMT.</pubDate>
      <lastBuildDate>Sun, 22 Jun 2008 18:40:04 GMT</lastBuildDate>
      <image>
         <title>Lung Cancer News</title>
         <url>http://poznaisebya.com/newseng/i/logo.png</url>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/</link>
      </image>

      <item>
         <title>Genetic Test For Lung Cancer Recurrence?</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-22-18-40-04-946.html</link>
         <description>The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-22-18-40-04-946.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sun, 22 Jun 2008 18:40:04 GMT</pubDate>
      </item>

      <item>
         <title>Vall D&#039;Hebron University Hospital And Cyclacel To Initiate Phase 1 Combination Study Of Seliciclib And Tarceva R In Advanced Cancers</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-13-635.html</link>
         <description>Vall d&#039;Hebron University Hospital and Cyclacel Pharmaceuticals,  Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced a collaboration to conduct a Phase 1 study of investigational therapy seliciclib in combination with erlotinib (Tarceva ) in patients with advanced solid tumors including non-small cell lung cancer (NSCLC).   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-13-635.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 21 Jun 2008 15:20:13 GMT</pubDate>
      </item>

      <item>
         <title>National Archives Reveals British Cabinet&#039;s First Discussion On Lung Cancer And Smoking</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-11-536.html</link>
         <description>The UK National Archives have just released notes of cabinet meetings that took place over 50 years ago,  from 1955 to 1956,  among which are minutes of a meeting where the British prime minister and cabinet colleagues first reviewed emerging evidence of a statistical link between smoking and lung cancer and made the decision to wait and see rather than mount a public campaign.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-11-536.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 21 Jun 2008 15:20:11 GMT</pubDate>
      </item>

      <item>
         <title>Study Showed Alimta R Pemetrexed For Injection Improved Survival In Certain Types Of Non-Small Cell Lung Cancer</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-10-114.html</link>
         <description>The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and,  in turn,  survival outcome according to the results of a major study published today in the Journal of Clinical Oncology.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-10-114.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 21 Jun 2008 15:20:10 GMT</pubDate>
      </item>

      <item>
         <title>Scientists From The University Of Navarra Find 5 Genes Involved In The Metastasis Of Breast Tumours To The Lung</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-08-828.html</link>
         <description>The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra,  the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-21-15-20-08-828.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Sat, 21 Jun 2008 15:20:08 GMT</pubDate>
      </item>

      <item>
         <title>Carrying Common Genetic Mutation Associated With Lung Cancer</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-06-622.html</link>
         <description>A common genetic disorder that has previously been linked to lungdisease may also put its carriers at a 70%-100% increased risk of lungcancer,  according to an article released on May 26,  2008 in the Archivesof Internal Medicine,  one of the JAMA/Archives journals.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-06-622.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 11:20:06 GMT</pubDate>
      </item>

      <item>
         <title>A New Way To Look At Lung Cancer And Tobacco Carcinogens</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-05-615.html</link>
         <description>Two types of cancer-causing agents in cigarettes a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-05-615.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 11:20:05 GMT</pubDate>
      </item>

      <item>
         <title>Researchers Optimistic About New Therapy For Lung Cancer</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-03-834.html</link>
         <description>An article in the July edition of The Lancet Oncologysuggests that a common treatment for liver cancer - radiofrequencyablation - can also be used to treat lung cancer.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-20-11-20-03-834.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Fri, 20 Jun 2008 11:20:03 GMT</pubDate>
      </item>

      <item>
         <title>Rosetta Genomics And M. D. Anderson To Develop A MicroRN Based Diagnostic Test To Identify Risk Of Recurrence Of Lung Cancer</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-19-08-00-04-237.html</link>
         <description>Rosetta Genomics,  Ltd. (NASDQ: ROSG),  a leader in the development of microRNA-based diagnostic and therapeutic products,  announced a research collaboration with The University of Texas M.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-19-08-00-04-237.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Thu, 19 Jun 2008 08:00:04 GMT</pubDate>
      </item>

      <item>
         <title>Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial</title>
         <link>http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-18-04-20-11-759.html</link>
         <description>Celecoxib,  the anti-inflammatory medication also known by the trade name Celebrex,  has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung,  according to a study from The University of Texas M.   
&lt;br&gt;&lt;p&gt;&lt;a href=http://poznaisebya.com/newseng/lung-cancer-news/news_2008-06-18-04-20-11-759.html&gt;Full text&lt;/a&gt;&lt;/p&gt;</description>
         <pubDate>Wed, 18 Jun 2008 04:20:11 GMT</pubDate>
      </item>

   </channel>
</rss>
